Stockscreener 앱 받기
0.3799
1.83%
-0.0071
시장 영업 전:
.37
-0.0099
-2.61%
Adial Pharmaceuticals Inc 주식(ADIL)의 최신 뉴스
Adial Pharmaceuticals Completes FDA Meeting, Advances AD04 into Phase 3 Clinical Development - AInvest
Adial Pharmaceuticals' Regulatory and Strategic Momentum with AD04: A Catalyst for Partnership and Growth in a High-Potential Market - AInvest
Adial Pharmaceuticals completes FDA meeting for alcohol disorder drug By Investing.com - Investing.com South Africa
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting | AD - GuruFocus
Adial Pharmaceuticals completes FDA meeting for alcohol disorder drug - Investing.com
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting - GlobeNewswire
Adial Pharmaceuticals Completes Successful FDA Meeting for Phase 3 Trial of AD04 for Alcohol Use Disorder Treatment. - AInvest
Candlestick Reversal Detected on Adial Pharmaceuticals Inc.’s ChartProfit Focused Trade Alerts - beatles.ru
Sentiment Tools Show Shift in Trader Mood on Adial Pharmaceuticals Inc.Weekly Stock Opportunity Radar Scanner Activated - beatles.ru
Technical Bounce Expected in Adial Pharmaceuticals Inc. Next WeekSector Based Breakout Stock Forecast Issued - metal.it
Published on: 2025-08-04 18:30:20 - beatles.ru
Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket - Benzinga
What is the risk reward ratio of investing in Adial Pharmaceuticals Inc. stockBuild wealth with reliable stock picks - Jammu Links News
How many analysts rate Adial Pharmaceuticals Inc. as a “Buy”Rapid growth opportunities - Jammu Links News
What drives Adial Pharmaceuticals Inc. stock priceTriple returns potential - Jammu Links News
How does Adial Pharmaceuticals Inc. generate profit in a changing economyBoost your returns with professional guidance - Jammu Links News
What analysts say about Adial Pharmaceuticals Inc. stockHigh-profit capital plays - Jammu Links News
How strong is Adial Pharmaceuticals Inc. company’s balance sheetFree Stock Selection - Jammu Links News
Adial Pharmaceuticals Approves Share Increase Amid Ongoing Financial Struggles - AInvest
What is Adial Pharmaceuticals Inc. company’s growth strategyGet timely alerts on market opportunities - Jammu Links News
What is the dividend policy of Adial Pharmaceuticals Inc. stockGet exclusive market analysis for investors - Jammu Links News
What are Adial Pharmaceuticals Inc. company’s key revenue driversMaximize returns with disciplined trading approaches - Jammu Links News
What catalysts could drive Adial Pharmaceuticals Inc. stock higher in 2025Dynamic growth stocks - Jammu Links News
Published on: 2025-08-03 01:06:20 - jammulinksnews.com
Is Adial Pharmaceuticals Inc. a growth stock or a value stockBreakout Stocks Tracker With High Returns - jammulinksnews.com
Adial Pharmaceuticals shareholders approve share increases and board proposals By Investing.com - Investing.com Australia
Adial Pharmaceuticals Enters New Sales Agreement - TipRanks
Adial Pharmaceuticals shareholders approve share increases and board proposals - Investing.com
Adial Pharmaceuticals Approves Share Increase at Annual Meeting - TipRanks
Adial Pharmaceuticals Inc. Plunges 10.55% Amid Investor Concerns - AInvest
SHEN files 8-K, releases Q2 2025 earnings press release | ADIL SEC FilingForm 424B5 - Stock Titan
What are the technical indicators suggesting about Adial Pharmaceuticals Inc.Chart Pattern Planner For Beginners - Jammu Links News
Adial Pharmaceuticals Inc. Plunges 16.67% in Pre-Market Trading - AInvest
Adial Pharmaceuticals Inc. Shows Risk Reward Favoring UpsideBuy Signal Based on Chart Analysis Confirmed - metal.it
Alcohol Use Disorder Pipeline 2025: Therapies Under - openPR.com
Should You Forget Palantir and Buy 2 Artificial Intelligence (AI) Stocks Instead? - The Globe and Mail
Published on: 2025-07-29 13:05:24 - metal.it
P&G Announces Fourth Quarter and Fiscal Year 2025 Results - The Globe and Mail
Adial Pharmaceuticals Soars 14.6% on Bullish Sentiment - AInvest
Adial Pharmaceuticals Inc. (ADIL) Soars 12.06% on Investor Optimism - AInvest
Ichimoku Cloud Indicates Uncertainty Around Adial Pharmaceuticals Inc.Entry Alert Based on Volume Spikes Detected - metal.it
Adial Pharmaceuticals Skyrockets 28.09% – What’s Fueling This Volcanic Surge? - AInvest
What makes NovaBay Pharmaceuticals Inc. stock price move sharplyBreakthrough stock performance - jammulinksnews.com
What are analysts’ price targets for Adial Pharmaceuticals Inc. in the next 12 monthsFind market-beating stocks for your portfolio - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):